{"id":"NCT00432276","sponsor":"Takeda","briefTitle":"Efficacy of Alogliptin and Pioglitazone in Subjects With Type 2 Diabetes Mellitus","officialTitle":"A Multicenter, Randomized, Double-Blind Study to Determine the Efficacy and Safety of the Addition of SYR-322 25 mg Versus Dose Titration From 30 mg to 45 mg of Pioglitazone HCl (ACTOS®) in Subjects With Type 2 Diabetes Mellitus Who Have Inadequate Control on a Combination of Metformin and 30 mg of Pioglitazone HCl Therapy","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-01","primaryCompletion":"2009-05","completion":"2009-06","firstPosted":"2007-02-07","resultsPosted":"2013-04-04","lastUpdate":"2013-04-04"},"enrollment":803,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Diabetes Mellitus"],"interventions":[{"type":"DRUG","name":"Alogliptin","otherNames":["SYR-322"]},{"type":"DRUG","name":"Pioglitazone","otherNames":["ACTOS®"]},{"type":"DRUG","name":"Metformin","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Alogliptin 25 mg + Pioglitazone 30 mg add-on to Metformin","type":"EXPERIMENTAL"},{"label":"Pioglitazone 45 mg add-on to Metformin","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of the study is to compare the effect of adding alogliptin, once daily (QD), to the ongoing treatment regimen of pioglitazone HCl and metformin in patients with inadequate glycemic control.","primaryOutcome":{"measure":"Change From Baseline in Glycosylated Hemoglobin (HbA1c)","timeFrame":"Baseline and Weeks 26 and 52.","effectByArm":[{"arm":"Alogliptin 25 mg + Pioglitazone 30 mg + Metformin","deltaMin":-0.89,"sd":0.042},{"arm":"Pioglitazone 45 mg + Metformin","deltaMin":-0.42,"sd":0.042}],"pValues":[{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":13,"exclusionCount":18},"locations":{"siteCount":86,"countries":["United States"]},"refs":{"pmids":["21733058"],"seeAlso":["http://general.takedapharm.com/content/file/pi.pdf?applicationcode=ab2d7112-8eb3-465a-8fda-35018a9eafb0&fileTypeCode=ACTOSPI"]},"adverseEventsSummary":{"seriousAny":{"events":20,"n":404},"commonTop":["Nasopharyngitis","Hypertension","Upper respiratory tract infection","Influenza","Diarrhoea"]}}